[1] |
Suzuki H,Fan R,Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity [J]. J Clin Invest, 2009, 119 (6): 1668-1677.
|
[2] |
Placzek WJ,Yanagawa H,Makita Y, et al. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy [J]. PLoS One, 2018, 13(1): e0190967.
|
[3] |
Suzuki H,Yasutake J,Makita Y, et al. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis [J]. Kidney Int, 2018, 93(3): 700-705.
|
[4] |
Wu J,Wang N,Wang J, et al. Identification of a uromodulin fragment for diagnosis of IgA nephropathy [J]. Rapid Commun Mass Spectrom, 2010, 24(14): 1971-1978.
|
[5] |
Wang N,Bu R,Duan Z, et al. Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy [J]. Peer J, 2015, 3: e990.
|
[6] |
Katafuchi R,Kiyoshi Y,Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation [J]. Clin Nephrol, 1998, 49(1): 1-8.
|
[7] |
Lee SM. Prognostic indicators of progressive renal disease in IgA nephropathy: emergence of a new histologic grading system [J]. Am J Kidney Dis, 1997, 29(6): 953-958.
|
[8] |
Haas M. Histology and immunohistology of IgA nephropathy [J]. J Nephrol, 2005, 18(6): 676-680.
|
[9] |
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification [J]. Kidney Int, 2009, 76(5): 534-545.
|
[10] |
Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility [J]. Kidney Int, 2009, 76(5): 546-556.
|
[11] |
Lv J,Shi S,Xu D, et al. Evaluation of the Oxford classification of IgA nephropathy: a systematic review and meta-analysis [J]. Am J Kidney Dis, 2013, 62(5): 891-899.
|
[12] |
Lv J,Yang Y,Zhang H, et al. Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study [J]. J Am Soc Nephrol, 2013, 24(12): 2118-2125.
|
[13] |
Haas M,Verhave JC,Liu ZH, et al. A multicenter study of the predictive value of crescents in IgA nephropathy [J]. J Am Soc Nephrol, 2017, 28(2): 691-701.
|
[14] |
Trimarchi H,Barratt J,Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group [J]. Kidney Int, 2017, 91(5): 1014-1021.
|
[15] |
Pozzi C,Bolasco PG,Fogazzi GB, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial [J]. Lancet, 1999, 353(9156): 883-887.
|
[16] |
Pozzi C,Andrulli S,Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial [J]. J Am Soc Nephrol, 2004, 15(1): 157-163.
|
[17] |
Samuels JA,Strippoli GF,Craig JC, et al. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials [J]. Nephrology (Carlton), 2004, 9(4): 177-185.
|
[18] |
Lv J,Zhang H,Wong MG, et al. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial [J]. JAMA, 2017, 318(5): 432-442.
|
[19] |
Rauen T,Eitner F,Fitzner C, et al. Intensive supportive care plus immunosuppression in IgA nephropathy [J]. N Engl J Med, 2015, 373(23): 2225-2236.
|
[20] |
Fellström BC,Barratt J,Cook H, et al. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial [J]. Lancet, 2017, 389(10084): 2117-2127.
|
[21] |
Xie Y,Chen X,Nishi S, et al. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy [J]. Kidney Int, 2004, 65(4): 1135-1144.
|
[22] |
Xie Y,Nishi S,Ueno M, et al. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy [J]. Kidney Int, 2003, 63(5): 1861-1867
|
[23] |
Liu LL,Wang LN,Jiang Y, et al. Tonsillectomy for IgA nephropathy: a meta-analysis [J]. Am J Kidney Dis, 2015, 65(1): 80-87.
|